Krzysztof Giannopoulos, MD, PhD

Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland, Poland

Poster(s):

• 1423 - MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)

• LB05 - Integrated immunogenetic and cytogenetic profiling reveals distinct biological patterns among stereotyped BCR subsets in CLL